79
43
Growth Score
-6 pts
Heat Score
0 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
1014126
Baxalta Incorporated (NYSE: BXLT) is a $6 billion global biopharmaceutical leader developing.
Johanna Kindermann: Senior Scientist
Todd Berner: Medical Director & Head of Global Medical Affairs Strategy ImmunologyPast Role: Endo Pharmaceuticals, Sr. Director of Health Outcomes Strategy & Clinical Development & Medical Sciences
About the Company
Baxalta Incorporated (Baxalta) is a biopharmaceutical company with a portfolio of differentiated therapies that seek to address medical needs across various disease areas, including hemophilia, immunology and oncology
